TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.30$ -2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -25.0% -92.3% -100.0% – -100.0% – +200.0% +25.0% +346.1% -16.7% +161.1%
– -51.2% -86.3% +614.3% -35.1% -4.4% -93.9% +1,033.3% +43.4% +105.5% +295.7% +16.7%
– -15.3% -93.6% -425.8% – -105.9% – +174.2% +22.7% +382.1% -36.6% +218.6%
– +40.9% +15.6% +16.4% +6.1% -34.6% +14.9% +26.1% +6.8% +12.5% -28.0% -8.3%
– +10.3% +22.3% +3.9% +5.3% +4.6% +16.6% +10.7% -5.0% -5.7% -3.0% -5.8%
– +33.7% +15.8% +13.1% +6.9% -27.8% +15.8% +20.8% +3.7% +6.1% -21.6% -7.6%
– – – – – – – – – – – –
– +128.8% -6.6% -27.9% +22.0% +191.8% -4.8% -49.6% -96.9% +14.8% +9.7% –
– – – – – – – – – – – –
– +8.3% -94.9% -3,490.0% – – – – – +15,365.5% -49.6% -98.8%
– – – – – – – – – – – –
– – – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?